Stanley Jacot Jr - Apr 4, 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Executive Officer
Signature
Stanley E. Jacot, Jr., by Attorney-in-fact, Solaeta Chan
Stock symbol
RKDA
Transactions as of
Apr 4, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 05:26 PM
Previous filing
Feb 4, 2022
Next filing
May 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +1.5K +18.98% $0.00 9.4K Apr 4, 2023 Common Stock 1.5K $7.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.